Spermin-Poehl (Sperminum-Poehl) organotherapy

injection · 1893–1908

category:injection

delivery:Standardized ampoules of a spermin-containing solution for subcutaneous injection (Poehl is credited with the technique of sealing sterile injection solutions in glass ampoules), with oral forms also marketed. The preparation was branded 'Sperminum-Poehl' and sold as a physician-prescribed organotherapeutic through Poehl's St. Petersburg pharmacy and its organotherapeutic centre and pharmaceutical factory, rather than as an over-the-counter tonic.

price tier:premium

era:1893–1908

current status:historical

regulatory:withdrawn

SHORT PITCH (AS SOLD)

Injected spermin, presented as an oxidation-catalyzing antitoxin that restores vital energy and reverses senile decline.

THE ACTUAL EVIDENCE

The claims rested on uncontrolled case-series reporting in Poehl's own publications (the 1894 metabolism-and-autointoxication monograph and the 1898 spermine-theory book), with no controlled comparison. Spermine is a real, ubiquitous cellular polyamine whose free base was characterized in the 1920s and whose biological role is binding nucleic acids and modulating cell growth (Lightfoot and Hall, Nucleic Acids Res 2014; Pegg, J Biol Chem 2018), not catalyzing tissue oxidation or neutralizing 'autointoxication'. At the turn of the century the commercial article called 'Spermin' was frequently piperazine rather than spermine, with the piperazine formula printed under the name spermine as late as 1903 (Mann, The Biochemistry of Semen, 1954). Poehl's pharmacological and clinical work was severely criticized and finally rejected; Mann notes spermine as a polyamine is not inert and is toxic parenterally in animals, so what failed is the rejuvenation-and-antitoxin doctrine, not the molecule's existence.

PRACTITIONERS

Alexander von Poehl

INGREDIENTS

Spermine (seminal and tissue polyamine)

CASES

poehl-spermine-1893-1908

CLAIMS

Administration of spermin ('Sperminum-Poehl') restores vital energy and checks senile decline, because the body's spermin diminishes with age and exogenous supplementation replaces the lost physiological factor. refuted
Spermin acts as a catalytic agent that increases oxidation in the tissues and as a physiological antitoxin that neutralizes 'autointoxication' (endogenous metabolic self-poisoning), including in uric-acid diathesis. refuted
Injected Sperminum-Poehl is an effective treatment for senile debility, neurasthenia, convalescent exhaustion, and male sexual weakness, across a range of conditions reported as treated successfully. refuted

SOURCES

NOTES

Spermin-Poehl was the branded organotherapeutic at the centre of Alexander von Poehl’s spermine theory: injected spermin sold as an oxidation-catalyzing antitoxin that would restore vital energy and check senile decline. It was a premium, physician-prescribed product distributed through Poehl’s own St. Petersburg pharmacy, organotherapeutic centre, and factory from the early 1890s until the firm wound down (the pharmacy was nationalized in 1918; the family enterprise ran to 1927). The intervention sits in the organotherapy lineage descending from Brown-Sequard’s 1889 testicular extract: a biologically real substance, loaded with a vital-principle interpretation it could not support, sold to the physician-attended patient of means on the promise of restored vigor. Its mechanism was a surrogate construct built on the autointoxication doctrine, and its evidence was uncontrolled case reporting in the promoter’s own literature.